for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reliv International, Inc

RELV.OQ

Latest Trade

4.48USD

Change

0.18(+4.19%)

Volume

1,250

Today's Range

4.30

 - 

4.48

52 Week Range

3.65

 - 

5.87

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
4.30
Open
4.30
Volume
1,250
3M AVG Volume
0.11
Today's High
4.48
Today's Low
4.30
52 Week High
5.87
52 Week Low
3.65
Shares Out (MIL)
1.75
Market Cap (MIL)
7.51
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2019 Reliv International Inc Earnings Release

Latest Developments

More

Reliv International Q2 Loss Per Share $0.22

Reliv International Reports Q1 EPS Of $0.36

Reliv International Q4 Loss Per Share $0.08

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Reliv International, Inc

Reliv' International, Inc. is a developer, manufacturer and marketer of a line of nutritional supplements addressing nutrition, specific wellness needs, weight management and sports nutrition. The Company sells its products through an international network marketing system using independent distributors. The Company offers approximately 20 nutritional supplements. The Company's nutritional supplement product line includes Reliv Classic and Reliv NOW, which are two basic nutritional supplements containing vitamins, minerals, protein and herbs; Innergize!, which is an isotonic sports supplement in approximately two flavors; FibRestore, which is a high-fiber and antioxidant supplement, and LunaRich X, which is a soy concentrate with elevated levels of lunasin, in capsule form. The Company's network consists of approximately 44,590 distributors, including over 32,270 in the United States and over 12,320 across its international markets.

Industry

Biotechnology & Drugs

Contact Info

136 Chesterfield Industrial Blvd

PO Box 405

+1.636.5379715

https://www.reliv.com

Executive Leadership

Robert L. Montgomery

Chairman of the Board

Ryan A. Montgomery

President, Chief Executive Officer

Carl W. Hastings

Vice Chairman of the Board, Chief Scientific Officer

Steven D. Albright

Chief Financial Officer, Senior Vice President

R. Scott Montgomery

President of Operations and International

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
0.21
Price To Book (MRQ)
0.64
Price To Cash Flow (TTM)
30.24
Total Debt To Equity (MRQ)
4.26
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-3.53
Return on Equity (TTM)
-2.45

Latest News

BRIEF-Reliv International Q3 loss per share $0.17

* Reliv International reports third-quarter financial results for 2017

BRIEF-Reliv International Q2 loss per share $0.28

* Reliv international reports second-quarter financial results for 2017

BRIEF-Reliv International reports Q1 EPS $0.28

* Reliv International reports first-quarter financial results for 2017

BRIEF-Reliv International reports Q4 earnings per share $0.15

* Reliv International reports fourth-quarter and full-year financial results for 2016

BRIEF-Reliv International reports third-quarter financial results for 2016

* Reliv International reports third-quarter financial results for 2016

BRIEF-Reliv international & units renewed revolving credit facility of $3.5 million- SEC filing

* On September 30, Co and units renewed a revolving credit facility with Enterprise Bank & trust of $3.5 million- SEC filing Source text for Eikon: Further company coverage:

BRIEF-Reliv International reports reverse stock split

* Says board set ratio of reverse stock split of company's outstanding common stock, par value $.001 per share, at one-for-seven

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up